15 April 2025 Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega ...

A new law affecting disputes concerning the ‘Bolar provision’ could allow competitors to enter the Ukrainian market before a ...

The new hire brings over 20 years of experience in patent prosecution and litigation involving pharmaceuticals, molecular ...

The firm’s new practice unites Faber’s transactional and licensing abilities with Crowell’s regulatory and litigation ...

The seasoned patent litigators join from Mayer Brown, bringing decades of high-stakes experience in pharma and biotech patent ...

Novo Nordisk faces resistance from Connecticut clinic in Ozempic and Wegovy dispute | LIVation admits to referencing Novo ...

Shilpa Medicare failed to prove invalidity of patent covering Lenvima | Eisai says ruling keeps India-based generic maker’s ...

UPC rejects jurisdictional challenges from Moderna | Court allows two linked infringement cases over mRNA tech to move ...

Fed Circ refuses to stay Novartis feud with MSN over Entresto ...

Baker McKenzie adds London partner with ‘enviable’ expertise ...

With the regime affecting UK exports to the EEA set to continue, Charlotte Peach of Taylor Wessing explores some of the ...

5 September 2024 AstraZeneca unit and Samsung Bioepis resolve their patent dispute over a biosimilar | Settlement follows FDA ...